Elewski, B.; Menter, A.; Crowley, J.; Tyring, S.; Zhao, Y.; Lowry, S.; Rozzo, S.; Mendelsohn, A.; Parno, J.; Gordon, K. Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis. J of Skin 2018, 2, S22.